The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Thermo Fisher Scientific
For pharmaceutical companies without their own facilities, choosing the right partner for latephase clinical trials and commercial production is a critical consideration in developing parenteral products. Small contract development and manufacturing organizations (CDMOs) can often provide early-phase material but may not always be able to move through to meet the rigorous demands of late stage and into commercialization. This article examines some of the key criteria for selecting the right CDMO partner and includes a case study that shares some challenges involved in a late-phase technology transfer for a parenteral product.